Navigation Links
Bionovo Announces Enrollment Started in the Menerba (MF101) Phase 1 "Tolerability" Clinical Trial for Menopausal Hot Flushes
Date:3/28/2011

EMERYVILLE, Calif., March 28, 2011 /PRNewswire/ -- Bionovo, Inc. (Nasdaq: BNVI), a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, today announced that enrollment has started for the Phase 1 clinical trial testing the safety of two doses of Menerba in postmenopausal women for the treatment of menopausal hot flushes (study # MF101-008), also known as "menopausal hot flashes."

This Phase 1, open-label, randomized, clinical trial of Menerba will be conducted at three clinical sites in Northern California. Forty postmenopausal women between the ages of 40 and 65 years will be randomized to one of two doses of Menerba and treated for 28 days. The primary goal of this study is to assess the safety of two doses of MF101 after 4 weeks of treatment. Dr. Wulf Utian will serve as the Principal Investigator for this study.

"We are pleased to announce that we are initiating the Phase 1 tolerability clinical trial. We are confident that the trial will proceed quickly and successfully. We are diligently executing on all our milestones, clinical and non-clinical activities, in 2011," commented Dr. Isaac Cohen, Chairman and Chief Executive Officer of Bionovo, Inc.

"This Phase 1 clinical trial is testing two doses of Menerba that are higher than the already proven efficacious dose evaluated in our Phase 2 trial, which showed efficacy equivalent to recently approved low dose menopausal hormone therapy (MHT). We are escalating the dose of Menerba to reach similar efficacy as the high doses of MHT. Our goal is to define a full therapeutic window that matches or improves on currently approved MHT drugs," said Mary Tagliaferri, M.D., Bionovo's President and Chief Medical Officer.

IRB approval has been granted at the two sites below, and enrollment will commence forthwith: 1.
Clinical Trials Re
'/>"/>

SOURCE Bionovo, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Bionovo Announces 2010 Highlights and Year-End Financial Results
2. Bionovo, Inc. to Announce Fourth Quarter Fiscal Year 2010 Financial Results on Tuesday, March 15, 2011
3. Bionovo to Present at the Cowen and Company 31st Annual Healthcare Conference
4. Bionovo Announces 2011 Plan of Action on MF101 (Menerba™)
5. Bionovo Announces Pricing of Follow-on Offering of Common Stock and Warrants
6. Bionovo Announces Publication Describing How Metabolic Adaptability Contributes to the Metastasis of Tumors
7. Bionovo Releases FDA-Approved Clinical Development Plan for Menerba
8. Bionovo Announces Publication Describing Estrogen Receptor Beta Cancer Prevention Mechanism
9. Bionovo Announces Third Quarter 2010 Highlights and Financial Results
10. Bionovo, Inc. to Announce Third Quarter Fiscal Year 2010 Financial Results on Thursday, November 11, 2010
11. Bionovo Announces Publication Describing Potential Estrogen Receptor Modulating Drugs for Treating Menopausal Conditions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... July 10, 2014 Decision Resources Group finds ... the U.S. Food and Drug Administration,s (FDA) approval of ... Velphoro, which was approved by the FDA in November ... disease (CKD) patients on dialysis. Other key ... (US) Q2 2014 : ...
(Date:1/15/2014)... Jan. 15, 2014 Most osteoporosis patients want a ... recent online survey* sponsored by Mission Pharmacal Company. The ... Osteoporosis Foundation online support community, revealed that 74 percent ... comes in a form other than a pill or ...
(Date:1/15/2014)... 15, 2014 AARP Foundation today announced it has established ... from the severe cold weather that has gripped much of ... those in need; so to support these emergency relief efforts ... $250,000, which could mean up to $500,000 in aid. The ...
Breaking Medicine Technology:Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis 2Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis 3Mission Pharmacal Conducts Online Survey of Osteoporosis Patients 2Mission Pharmacal Conducts Online Survey of Osteoporosis Patients 3AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 2AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 3
... N.J., Oct. 30 Novo Nordisk Inc. announced the ... hemophilia(TM) campaign through a rebranded Web site and ... face many daily challenges, and Novo Nordisk is committed ... a lifetime of possibilities. , These new online resources ...
... GUANGZHOU, China, Oct. 30 ... CHME) ("China Medicine" or "the Company"), a ... pharmaceuticals,traditional Chinese medicines ("TCM"), nutritional and dietary ... announced that through its,wholly-owned subsidiary in China, ...
Cached Medicine Technology:Novo Nordisk is Changing Possibilities in Hemophilia 2Novo Nordisk is Changing Possibilities in Hemophilia 3China Medicine Corporation to Acquire Pharmaceutical Manufacturer in Guangzhou 2China Medicine Corporation to Acquire Pharmaceutical Manufacturer in Guangzhou 3China Medicine Corporation to Acquire Pharmaceutical Manufacturer in Guangzhou 4
(Date:7/11/2014)... 11, 2014 Utilizing the Keller Funnel, ... William Koenig, has topped a record number of complication-free ... performed over 400 successful procedures without the occurrence of ... well known across the country for his expertise with ... has long been the foundation for numerous studies and ...
(Date:7/11/2014)... Ticket Down is a reliable source ... When it comes to the summer concert schedule, it just ... native is one of the biggest names in country music and ... currently out on his “That’s My Kind of Night” tour featuring ... will be making through the rest of the summer and into ...
(Date:7/11/2014)... are widely applied in turf and ornamentals. They enhance ... turf and ornamentals in absorption of water, nutrient uptake, ... appear healthy and strong as a result of using ... few years. The most dominating region in biostimulants markets ... share in 2013, and is estimated to grow at ...
(Date:7/11/2014)... PULLMAN, Wash.The largest study of its kind has ... suite of advantages over their conventional counterparts, including ... , The study looked at an unprecedented 343 ... of organic and conventional plant-based foods, including fruits, ... meta-analysis techniques to quantify differences between organic and ...
(Date:7/11/2014)... Ticket Down is a reliable source for cheap Luke ... Over the years Luke Bryan has been honored by almost every ... well at award shows, but each summer, he hits the road ... the genre and this summer is more of the same. When ... popularity and success that is currently entitled to Luke Bryan. The ...
Breaking Medicine News(10 mins):Health News:Rochester Surgeon Hits Milestone with Keller Funnel 2Health News:Luke Bryan Ticket Prices Slashed at Concord Pavilion 2Health News:Luke Bryan Ticket Prices Slashed at Concord Pavilion 3Health News:Biostimulants Market in Turf and Ornamentals is Expected to Reach $ 3.8 Billion by 2018 - New Report by MicroMarket Monitor 2Health News:Biostimulants Market in Turf and Ornamentals is Expected to Reach $ 3.8 Billion by 2018 - New Report by MicroMarket Monitor 3Health News:Major study documents nutritional and food safety benefits of organic farming 2Health News:Major study documents nutritional and food safety benefits of organic farming 3Health News:Luke Bryan Tickets Shoreline Amphitheatre in Mountain View, CA: Ticket Down Slashes Ticket Prices for Luke Bryan in Mountain View at the Shoreline Amphitheatre 2Health News:Luke Bryan Tickets Shoreline Amphitheatre in Mountain View, CA: Ticket Down Slashes Ticket Prices for Luke Bryan in Mountain View at the Shoreline Amphitheatre 3
... complaints show it may not be for everyone , , FRIDAY, ... vision-correcting LASIK surgery as "life changing." NASA now allows astronauts ... has been performed on 112,500 military personnel, including pilots. ... this elective surgery being lost in this laudatory celebration? ...
... of Deep Brain Stimulation, or ,Brain,Pacemakers, on the ... WASHINGTON, April 25 The U.S. Department ... are teaming up to,raise awareness about deep brain ... disorders and disabilities., HHS, Office on Disability ...
... Leinbach, a,9-year-old student in Mrs. Sheri Fetterhoff,s ... County, will receive a $1,000,educational bond for ... 2008 National Children,s Dental Health Month (NCDHM),statewide ... reproduced as bookmarks, which will be,distributed to ...
... The United States,Agency for International Development (USAID) is ... solution that reduces the risk of,diarrhea. Sur,Eau is ... chlorine solution can be added to water immediately ... principally young children and,people living with HIV and ...
... April 25 The Michigan,Chamber of Commerce today announced ... find its way to the November 2008 ballot and,constitutionally ... care system. The Michigan Chamber cited serious concerns with ... and the fact,that Michigan job providers and taxpayers would ...
... 25 SynergEyes, Inc., of Carlsbad, CA,recently launched ... need further vision correction after undergoing refractive vision,surgery. ... who,have experienced some type of corneal trauma or ... millions of people undergo LASIK or other types ...
Cached Medicine News:Health News:FDA Panel Urges Stronger Warnings for LASIK Surgery 2Health News:FDA Panel Urges Stronger Warnings for LASIK Surgery 3Health News:FDA Panel Urges Stronger Warnings for LASIK Surgery 4Health News:HHS, Cleveland Clinic Collaborate to Advance Treatment for Neurological Disorders 2Health News:HHS, Cleveland Clinic Collaborate to Advance Treatment for Neurological Disorders 3Health News:Pennsylvania Dental Association Announces Winners of Annual Statewide Third-grade Student Poster Contest 2Health News:Disinfecting Water Saves Lives in Rwanda 2Health News:Michigan Chamber of Commerce Opposes 'Blank Check' Healthcare Ballot Proposal 2Health News:SynergEyes Hybrid Contact Lenses Provide a Vision Solution for Post-LASIK Patients 2
Double ended with 0.5 mm x 10 mm and 0.5 mm x 15 mm blades. Both blades gently curved. Square serrated handle with polished finish. Most popular size or model....
11 mm angled tip with gently curved blade. Flat serrated handle with polished finish....
Angled tip with gently curved blade. Short hexagonal handle with polished finish. 0.5 mm x 15 mm tip....
Double ended with 0.5 mm by 10 mm and 0.5 mm by 15 mm blades. Both ends are sharp with gently curved blades. Square serrated handle with polished finish. Most popular size or model....
Medicine Products: